Company · CIK 0001782223 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Pyxis Oncology, Inc. · PYXS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 AForm 4 → | Sep 8, 7:41 am EDT | Thomas CivikCEO & Chairman of the Board, Director | 2,503,050 | — | — | 2,503,050 | — |